| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.4M | -84.0% |
| Cost of Revenue | $1.6M | -88.7% |
| Gross Profit | $847K | -22.4% |
| R&D Expense | $0 | — |
| SG&A Expense | $1.0M | +48.2% |
| Operating Income | -$3.3M | -25.4% |
| Pre-tax Income | -$4.6M | +17.4% |
| Income Tax | $22K | +0.0% |
| Net Income | -$4.6M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $62K | -30.7% |
| Accounts Receivable | $398K | — |
| Inventory | $497K | -49.0% |
| Current Assets | $3.2M | -52.9% |
| Total Assets | $8.7M | -20.5% |
| Current Liabilities | $6.7M | +38.7% |
| Total Liabilities | $6.8M | +34.1% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.6M | +25.6% |
| Capital Expenditures | $5K | +0.0% |
| Investing Cash Flow | $161K | +150.6% |
| Financing Cash Flow | $3.4M | -33.8% |
| Free Cash Flow | -$3.6M | +25.5% |
| +19.6% |
| EPS (Basic) | -$1.60 | -1242.9% |
| EPS (Diluted) | -$1.60 | -1242.9% |
| Stockholders' Equity |
| $1.9M |
| -62.9% |